MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 137 filers reported holding MANNKIND CORP in Q2 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $318,000 | +14.8% | 499,940 | +11.9% | 0.00% | – |
| Q3 2016 | $277,000 | -52.8% | 446,740 | -11.8% | 0.00% | -100.0% |
| Q2 2016 | $587,000 | -11.3% | 506,225 | +23.0% | 0.00% | 0.0% |
| Q1 2016 | $662,000 | +4.6% | 411,425 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $633,000 | -55.4% | 436,540 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,420,000 | -43.7% | 442,280 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $2,520,000 | +9.4% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,303,000 | -0.3% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,309,000 | -11.8% | 442,840 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,617,000 | -46.1% | 442,840 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $4,854,000 | +216.4% | 442,840 | +16.1% | 0.00% | +300.0% |
| Q1 2014 | $1,534,000 | +5.6% | 381,506 | +36.9% | 0.00% | 0.0% |
| Q4 2013 | $1,452,000 | -9.2% | 278,606 | -0.7% | 0.00% | -50.0% |
| Q3 2013 | $1,599,000 | -28.9% | 280,545 | -18.9% | 0.00% | 0.0% |
| Q2 2013 | $2,248,000 | – | 345,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |